Sort
48,018 grants matching “immunotherapy”
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
$399,995Kevin J Cullen · University Of Maryland Baltimore · P30 · FY2020 · CA
Modulation of cancer induced immune suppression via inhibition of SCD1
$399,986Karen E Hayes · Modulation Therapeutics, Inc. · R44 · FY2022 · CA
Development of a potent and highly brain-penetrable antimitotic agent SEAK193 to treat breast cancer brain metastasis
$399,981Wei Li · Seak Therapeutics, Llc · R41 · FY2025 · CA
TOPIC 414 : SYNTHETIC BIOLOGY GENE CIRCUITS FOR CANCER THERAPY
$399,962Anna Simon · Strand Therapeutics Inc · N43 · FY2021 · CA
SaefCAR: Regulatable CAR-T cells for safe and effective immunotherapy
$399,958Yemi Onakunle · Mabswitch, Inc. · R43 · FY2023 · CA
Development of Highly Multiplex Antigen Specificity Assays
$399,956Harry Benjamin Larman · Johns Hopkins University · U24 · FY2015 · AI
CD3 bispecific for the treatment of ROR2-positive NSCLC
$399,955Jean-Loup Romet-Lemonne · Traverse Biotech Ii Inc · R43 · FY2023 · CA
Developmental Funds
$399,936Dario C. Altieri · Wistar Institute · P30 · FY2021 · CA
Developmental Funds
$399,936Dario C. Altieri · Wistar Institute · P30 · FY2022 · CA
Developmental Funds
$399,936Dario C. Altieri · Wistar Institute · P30 · FY2023 · CA
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
$399,918William Valentine Williams · Briacell Therapeutics Corp · R43 · FY2023 · CA
Automated plasma EV-PDL1 analysis for cancer immunotherapy
$399,913Liyun Jessica Sang · Accure Health, Inc. · R43 · FY2022 · CA
ApoFasL as a novel treatment for Type 1 Diabetes in Nonhuman Primates
$399,912Kathryn J. Macleod · Apovax, Inc. · R41 · FY2011 · DK
Retinal Remodeling
$399,904Bryan William Jones · University Of Utah · R01 · FY2020 · EY
Retinal Remodeling
$399,904Bryan William Jones · University Of Utah · R01 · FY2019 · EY
Development and Pre-Clinical Validation of Quantitative Imaging of Cell State Kinetics (QuICK) for Functional Precision Oncology
$399,891Thomas Andrew Zangle · Utah State Higher Education System--University Of Utah · R01 · FY2025 · CA
Minimally invasive quantitative tissue oxygen sensors to personalize cancer care
$399,888Gregory Ekchian · Stratagen Bio, Inc. · R43 · FY2023 · CA
Human specific STING agonists for the treatment of cancer
$399,812Glen N Barber · Stinginn, Llc · R41 · FY2023 · CA
Novel Approach to High-Throughput Identification and Characterization of Neoantigen-Specific T-Cell Receptors to Guide Immunotherapy Development.
$399,807Magali Soumillon · Flexomics Llc · R43 · FY2020 · CA
Chemotherapy delivery with nanoparticles for targeted induction of immunogenic cell death
$399,806Yoon Yeo · Purdue University · R01 · FY2022 · CA
ALLOGENIC PANCREATIC TUMOR VACCINE CELL LINE
$399,791Johns Hopkins University · R01 · FY2000 · CA
Acoustothermogenetics for Cell Engineering
$399,779Yingxiao Wang · University Of California, San Diego · R35 · FY2022 · GM
Immunological Analysis of Brain Cancer
$399,752Masaki Terabe · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Modulation of the gut microbiome to enhance efficacy of immunotherapy in pancreatic adenocarcinoma
$399,752Deepak Saxena · Periomics Care, Llc · R41 · FY2020 · CA
Highly Attenuated Vesiculovirus-based Vectors as HBV Therapeutic Vaccines
$399,750Michael D Robek · Albany Medical College · R01 · FY2020 · AI